(Q39474739)

12 September 2017

title

Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis (English)

1 reference

12 September 2017

main subject

Pseudomonas aeruginosa

0 references

cystic fibrosis

0 references

author name string

Kosorok MR

1

1 reference

12 September 2017

Jalaluddin M

2

1 reference

12 September 2017

Farrell PM

3

1 reference

12 September 2017

Shen G

4

1 reference

12 September 2017

Colby CE

5

1 reference

12 September 2017

Laxova A

6

1 reference

12 September 2017

Rock MJ

7

1 reference

12 September 2017

Splaingard M

8

1 reference

12 September 2017

publication date

1 August 1998

1 reference

12 September 2017

published in

Pediatric Pulmonology

1 reference

12 September 2017

volume

26

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

81-88

1 reference

Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Management of pulmonary disease in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Research in cystic fibrosis (first of three parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Long-Term Evaluation of Decontamination of Inhalation-Therapy Equipment and the Occurrence of Necrotizing Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

The changing epidemiology of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-0496%28199808%2926%3A2%3C81%3A%3AAID-PPUL2%3E3.0.CO%3B2-K

10.1002/(SICI)1099-0496(199808)26:2<81::AID-PPUL2>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

release_okovbvstprhjhigytumclfcf4i

12 September 2017

Fatcat ID

0 references

1 reference